LONDRES, Dec. 16, 2024 (GLOBE NEWSWIRE) — A Read more »
FLUX FINAL DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Flux Power Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – FLUX
NEW YORK, Dec. 14, 2024 (GLOBE NEWSWIRE) —
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Flux Power Holdings, Inc. (NASDAQ: [...] Read more »
MAPS DEADLINE ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages WM Technology, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important December 16 Deadline in Securities Class Action First Filed by the Firm – MAPS
NEW YORK, Dec. 14, 2024 (GLOBE NEWSWIRE) —
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of WM Technology, Inc. (NASDAQ: MAPS) [...] Read more »
LILM, LILMF DEADLINE NOTICE: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Lilium N.V. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – LILM, LILMF
NEW YORK, Dec. 14, 2024 (GLOBE NEWSWIRE) —
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lilium N.V. (NASDAQ: LILM) (OTC: LILMF) [...] Read more »
TD IMPORTANT DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages The Toronto-Dominion Bank Investors with Losses in Excess of $100K to Secure Counsel Before Important December 23 Deadline in Securities Class Action – TD
NEW YORK, Dec. 14, 2024 (GLOBE NEWSWIRE) —
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of The Toronto–Dominion Bank [...] Read more »
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – SAVA
NEW YORK, Dec. 14, 2024 (GLOBE NEWSWIRE) —
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of [...] Read more »
FAAM-EUROBAT 2024 schließt mit bahnbrechenden Fortschritten in der Forschung zu Nahrungsmittelallergien und Anaphylaxie
ATHEN, Griechenland, Dec. 13, 2024 (GLOBE NEWSWIRE) — Die FAAM–EUROBAT 2024, die vom 21. bis 23. November im InterContinental Athenaeum Athen stattgefunden hat, hat über [...] Read more »
L’édition 2024 du congrès FAAM-EUROBAT s’achève sur des avancées révolutionnaires en matière de recherche sur les allergies alimentaires et l’anaphylaxie
ATHÈNES, Grèce, 13 déc. 2024 (GLOBE NEWSWIRE) — L’édition 2024 du congrès FAAM–EUROBAT, organisé du 21 au [...] Read more »
O FAAM-EUROBAT 2024 termina com avanços inovadores na investigação de alergias alimentares e anafilaxia
ATENAS, Grécia, Dec. 13, 2024 (GLOBE NEWSWIRE) — O FAAM–EUROBAT 2024, realizado de 21 a 23 de novembro na InterContinental Athenaeum Athens, reuniu mais de 550 [...] Read more »
Cinq graphiques qui définissent la transition énergétique
LONDRES, HOUSTON et SINGAPOUR, 13 déc. 2024 (GLOBE NEWSWIRE) — Dans un contexte de transformation rapide du paysage énergétique en raison de la décarbonisation, de l’électrification et des [...] Read more »
Cinco gráficos que definem a transição energética
LONDRES e HOUSTON e SINGAPURA, Dec. 13, 2024 (GLOBE NEWSWIRE) — À medida que o cenário energético se transforma rapidamente devido à descarbonização, eletrificação e [...] Read more »
Fünf Grafiken, die die Energiewende definieren
LONDON, HOUSTON und SINGAPUR, Dec. 13, 2024 (GLOBE NEWSWIRE) — Da sich die Energielandschaft aufgrund von Dekarbonisierung, Elektrifizierung und geopolitischen Veränderungen rasch wandelt, hat Wood Mackenzie im neuesten [...] Read more »
Bombardier annonce des changements à son conseil d’administration
MONTRÉAL, 13 déc. 2024 (GLOBE NEWSWIRE) — Bombardier est heureuse d’annoncer la nomination de madame Bettina Fetzer à son conseil d’administration, laquelle [...] Read more »
Bombardier Announces Changes to its Board of Directors
MONTRÉAL, Dec. 13, 2024 (GLOBE NEWSWIRE) — Bombardier is pleased to announce the appointment of Ms. Bettina Fetzer to its Board of Directors, effective January 1, 2025.
Read more »
Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England
Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England
First patients implanted with Genio at UCLH, London
Read more »